(Q26852299)

main subject

hepatocellular carcinoma

1 reference

Hans J. Schlitt

1

1 reference

Andreas A. Schnitzbauer

series ordinal

2

1 reference

language of work or name

1 reference

November 2011

1 reference

published in

Liver Transplantation

1 reference

volume

17 Suppl 3

1 reference

page(s)

S10-2

1 reference

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

cites work

1 reference

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

21 January 2018

1 reference

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

21 January 2018

1 reference

Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients

21 January 2018

1 reference

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

mTOR, cancer and transplantation.

21 January 2018

1 reference

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

Framework models of tumor dormancy from patient-derived observations

21 January 2018

1 reference

Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression

21 January 2018

1 reference

Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma

21 January 2018

1 reference

7 January 2021

Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma

1 reference

7 January 2021

A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma

1 reference

7 January 2021

Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.

1 reference

7 January 2021

Identifiers

DOI

10.1002/LT.22411

0 references

PubMed publication ID

21850696

1 reference